PE firms near club deal for majority stake in Anjan Drug

By Bruhadeeswaran R

  • 26 Aug 2020
Premium
Credit: Thinkstock

Two homegrown private equity firms have teamed up with an Asian alternative investment firm to strike a deal for Chennai-based Anjan Drug Pvt. Ltd, three people close to the development said. CX Partners, Samara Capital and a Hong Kong-based investment firm have come together to float a Singapore-based entity to acquire ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.